Australian Healthtech Stock News

Qoria Limited has announced it will release its first quarter 2026 financial results and hold an earnings call on October 21, 2025. Anticipation surrounding this upcoming earnings release is drawing greater investor attention to Qoria as market participants look for fresh insights into the company's performance and direction. To explore how this anticipation may influence Qoria's investment narrative, we'll focus on the heightened attention around its forthcoming earnings announcement. The...

Earlier this week, Northern Minerals received non-binding and conditional letters of support from the U.S. Export-Import Bank and Export Finance Australia for potential debt funding of up to US$230 million to advance the Browns Range heavy rare earths project in Western Australia. This international government backing reflects the project's positioning within a broader US-Australia push to develop independent global supply chains for critical minerals such as dysprosium and terbium. We'll...

VHM (ASX:VHM) has captured attention after announcing up to A$75 million in financial support from Export Finance Australia for its Goschen rare earths and mineral sands project. This announcement comes at a time of growing institutional interest in critical minerals. See our latest analysis for VHM. VHM’s recent institutional support landed against the backdrop of a surging share price, with a 214.89% share price return over the past month and a 70.11% total shareholder return in the past...

St George Mining (ASX:SGQ) just unveiled high-grade rare earths and niobium drilling results at its Araxá project in Brazil, sending shares up nearly 11%. The new intercepts extend mineralisation beyond existing resource boundaries and have sparked strong market interest. See our latest analysis for St George Mining. Momentum has accelerated for St George Mining in recent months, with its recent Araxá discovery and October equity raise sparking renewed investor interest. The share price has...

Key Insights MA Financial Group's significant individual investors ownership suggests that the key decisions are...

Key Insights Insiders appear to have a vested interest in GenusPlus Group's growth, as seen by their sizeable ownership...

Reliance Worldwide Corporation Limited's ( ASX:RWC ) price-to-earnings (or "P/E") ratio of 16.5x might make it look...

Recent third-party validation of Silex Systems (ASX:SLX) laser-based uranium enrichment technology has sparked considerable market interest. The confirmation that it is now commercially ready and can help boost US uranium enrichment capacity has contributed to this attention. See our latest analysis for Silex Systems. The upbeat news around Silex Systems’ laser enrichment breakthrough has clearly sparked fresh excitement, sending its share price up nearly 48% over the last month and over 92%...

Paradigm Biopharmaceuticals Limited presented at the Ignite Investment Summit in Hong Kong on October 15, 2025, with Founder, MD & Executive Chairman Paul John Rennie delivering key insights. The company's participation at this high-profile investor event provided stakeholders with detailed updates on its strategic direction and executive leadership vision. We'll explore how Paradigm Biopharmaceuticals' focus on its executive leadership vision at the summit shapes its current investment...

As the Australian share market edges towards a soft upswing, buoyed by global political developments and commodity price movements, investors are keenly observing potential opportunities. Penny stocks, though often seen as a term from past market eras, continue to hold relevance for those looking to explore beyond established names. These smaller or newer companies can offer affordability and growth potential when backed by robust financials; in this article, we highlight three such penny...

Northern Minerals (ASX:NTU) just got a major confidence boost from both U.S. and Australian government agencies, as they issued coordinated letters of intent and support for potential debt funding of the Browns Range rare earths project. This cross-border backing highlights how crucial rare earths are becoming for clean energy and defense supply chains globally. See our latest analysis for Northern Minerals. This wave of high-level government support has sent Northern Minerals’ share price...

Key Insights The considerable ownership by individual investors in New Murchison Gold indicates that they collectively...

Codan Limited recently reported a strong financial result for FY25, achieving 22% group revenue growth and marked increases in EBIT and NPAT, following the acquisition of Kägwerks to strengthen its U.S. defense market presence. The Communications division, including Zetron and DTC, posted a 26% revenue rise, while Minelab benefited from elevated gold prices and expanded distribution channels for a 16% increase. We’ll examine how Codan’s successful acquisition of Kägwerks and uplift in core...

Perpetual (ASX:PPT) saw total assets under management rise by 2.3%, even as net outflows and currency headwinds weighed on results. The company’s ongoing wealth business sale also remains in focus for investors. See our latest analysis for Perpetual. Despite resilient operating updates, Perpetual’s share price recently slipped to $19.30 after some short-term weakness, with a 7.7% drop over the past week that offset modest gains posted earlier in the month. Still, the longer-term total...

The Australian market showed a mixed performance recently, with energy stocks leading the way due to geopolitical factors and materials remaining steady. In this context, penny stocks continue to attract attention for their potential to offer unique growth opportunities. Although the term "penny stocks" might seem outdated, these smaller or newer companies can still be promising investments when backed by strong financials and solid fundamentals.

Botanix Pharmaceuticals (ASX:BOT) is drawing fresh attention this month as the company prepares for a major conference appearance, has updated investors on recent performance and product rollouts, and introduced a new joint company secretary to its leadership team. See our latest analysis for Botanix Pharmaceuticals. After a series of notable updates, including the appointment of a seasoned company secretary and an upcoming presentation at the Canaccord Genuity Drug & Device Conference,...

Earlier this week, HUB24 reported record quarterly net inflows of A$5.2 billion for Q1 FY26, pushing total funds under administration to A$146.5 billion as of September 30 and reflecting a 28% increase in inflows compared to the same period last year. An interesting development was the CEO’s recent significant share purchase, highlighting leadership confidence amid a rising share of retail users and new operational milestones. Let's examine how HUB24's exceptional inflows and funds under...

Paradigm Biopharmaceuticals (ASX:PAR) is drawing increased attention ahead of its scheduled presentation at the Ignite Investment Summit in Hong Kong, where the company’s founder and executive team will address investors. See our latest analysis for Paradigm Biopharmaceuticals. After a year defined by volatility, Paradigm's share price has rebounded sharply with a 56% gain over the past month. This signals fresh momentum ahead of its summit appearance. While the short-term rally is grabbing...

As global markets navigate a volatile landscape marked by easing monetary policies from the U.S. Federal Reserve and fluctuating trade tensions, small-cap stocks have shown resilience, with indices like the Russell 2000 reflecting a notable year-to-date increase. In this environment, identifying promising small-cap opportunities involves looking for companies that demonstrate strong fundamentals and potential for growth amidst broader economic uncertainties.

Qoria (ASX:QOR) has announced it will release its Q1 2026 results and host an earnings call on October 21. These events often prompt close attention from investors reviewing recent business trends and performance. See our latest analysis for Qoria. After a series of upbeat trading sessions ahead of the upcoming results, Qoria’s share price has climbed 30% over the past month and boasts a year-to-date return of 80%. Notably, its total shareholder return has more than doubled over the past...

Earlier this week, Prime Minister Anthony Albanese and US President Donald Trump announced a landmark US–Australia critical-minerals pact worth US$8.5 billion to advance key rare-earths projects and enhance bilateral government support for critical minerals supply chains. This high-profile international agreement highlights rising government interest in boosting domestic development for companies operating in Australia’s critical minerals sector, including WA1 Resources. We'll explore how...

American Rare Earths announced it has achieved a significant breakthrough in impurity removal at its Halleck Creek Rare Earths Project in Wyoming, reducing the formation of challenging byproducts and streamlining ore processing steps. This technical milestone is important for potentially lowering both capital and operating costs, as well as improving rare earth element yields, a key advancement for supply chain diversification in the United States. With a major impurity removal hurdle...

The Australian market is experiencing a cautious atmosphere, influenced by a technology selloff in the U.S. and recent fluctuations in gold prices. Despite these challenges, investors continue to seek opportunities that align with current market conditions. Penny stocks, though an older term, still represent potential growth avenues through smaller or newer companies that demonstrate strong financial health. In this article, we explore three such penny stocks that offer both affordability and...

Key Insights The considerable ownership by individual investors in Medibank Private indicates that they collectively...